Page last updated: 2024-08-24

ibandronic acid and Mandibular Diseases

ibandronic acid has been researched along with Mandibular Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diz, P; Feijoo, JF; García, A; Limeres, J; López-Cedrún, JL; Peñarrocha, M; Sanromán, JF1
Acham, S; Jakse, N; Kirnbauer, B; Rugani, P; Truschnegg, A1
Burian, E; Ehrenfeld, M; Mahaini, S; Otto, S; Pautke, C; Probst, F; Smolka, W; Troeltzsch, M1
Armonis, BN; Migliorati, CA; Nicolatou-Galitis, O1
Bhattacharyya, I; Bowers, LM; Cohen, DM; Fitzpatrick, SG; Green, JG; Hinkson, DW; Neuman, AN; Stavropoulos, MF1
Ganesan, K; Russell, J; Shah, K; Yankova, Z1
Fietkau, R; Gundlach, KK; Lenz, JH; Mueller, PC; Schmidt, W; Steiner-Krammer, B1
Márton, I; Redl, P; Udvardy, E1

Reviews

2 review(s) available for ibandronic acid and Mandibular Diseases

ArticleYear
Bisphosphonate-related osteonecrosis of the mandible secondary to postural pressure.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:7

    Topics: Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cervical Vertebrae; Clavicle; Diphosphonates; Female; Humans; Ibandronic Acid; Kyphosis; Mandibular Diseases; Posture; Pressure Ulcer

2012
[Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Magyar onkologia, 2008, Volume: 52, Issue:1

    Topics: Alendronate; Anti-Infective Agents; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Mandible; Mandibular Diseases; Oral Hygiene; Oral Surgical Procedures; Osteonecrosis; Patient Care Team; Referral and Consultation; Zoledronic Acid

2008

Other Studies

7 other study(ies) available for ibandronic acid and Mandibular Diseases

ArticleYear
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
    The British journal of oral & maxillofacial surgery, 2013, Volume: 51, Issue:8

    Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Dental Implants; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hypertension; Ibandronic Acid; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Retrospective Studies; Risedronic Acid; Risk Factors; Time Factors

2013
Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
    The Journal of oral implantology, 2015, Volume: 41 Spec No

    Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Regeneration; Crowns; Debridement; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis, Implant-Supported; Diphosphonates; Female; Follow-Up Studies; Humans; Ibandronic Acid; Mandible; Mandibular Diseases; Middle Aged; Osseointegration; Tooth Extraction; Tooth Socket

2015
Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2015, Volume: 43, Issue:9

    Topics: Adolescent; Adult; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pain; Recurrence; Retrospective Studies; Visual Analog Scale; Young Adult

2015
Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 106, Issue:1

    Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Mandibular Diseases; Osteonecrosis

2008
Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:2

    Topics: Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Mandibular Diseases; Maxillary Diseases; Middle Aged; Osteoporosis, Postmenopausal; Risedronic Acid; Tooth Extraction; Tooth Socket; Zoledronic Acid

2012
Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2005, Volume: 33, Issue:6

    Topics: Adult; Aged; Bone Density Conservation Agents; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Mandibular Diseases; Maxillary Diseases; Multiple Myeloma; Osteomyelitis; Osteonecrosis; Zoledronic Acid

2005
Bisphosphonates. A cornerstone of osteoporosis treatment.
    Mayo Clinic women's healthsource, 2007, Volume: 11, Issue:5

    Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Ibandronic Acid; Mandibular Diseases; Osteonecrosis; Osteoporosis; Risedronic Acid

2007